New stock news | BeTong intelligent delivery listing on the Hong Kong Stock Exchange
According to the Hong Kong Stock Exchange disclosure on December 2nd, BrightSmart Securities International Holdings Limited (BrightSmart) has submitted an application to list on the Hong Kong Stock Exchange Main Board.
According to the disclosure by the Hong Kong Stock Exchange on December 2, Beijing Vastdata Technology Holdings Limited (Vastdata Intelligence) submitted an application to the main board of the Hong Kong Stock Exchange, with BOC International as its sole sponsor. The prospectus shows that Vastdata Intelligence is a leading data-enabled business in the Chinese medical and health industry. The company has built an all-element intelligent data platform for the medical and health industry based on the assets and industry expertise of Beijing Vastdata Technology, leveraging its proven and scalable business model and industry synergies to achieve full coverage of the entire product life cycle in the medical and health industry and seamless integration across all channels in the pharmaceutical circulation sector.
The prospectus mentions that, according to a Frost & Sullivan report, Vastdata Intelligence pioneered the Direct Data Interchange (DDI) solution within the China Meheco Group and the medical device industry in 2009.
The DDI model enables direct, structured, and automated data exchange between production enterprises and numerous distributors and sales terminals, thereby improving data accuracy, enhancing the traceability of complex distribution networks, and supporting more efficient channel supervision and compliance management. According to the Frost & Sullivan report, by 2024, in terms of revenue, Vastdata Intelligence ranks second among third-party digital service providers for China Meheco Group and medical device enterprises.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






